author-photo

Sachith Gallolu Kankanamalage

University of Texas Southwestern Medical Center

17

Papers

144

Citations

Citation Trend

Filter By

Papers (17) Sort By

Journal Conference Others

Abstract LB068: A novel CD20/CD3 T cell engager designed from Rituximab targeting CD20+ cancer with multiple mechanisms

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Optimization of therapeutic antibodies

2021
Show All
- Source
- Cite
- Save
Citations (1)
Development of humanized tri-specific nanobodies with potent neutralization for SARS-CoV-2 (vol 10, 17806, 2020)

2021 Scientific Reports
Show All
- Source
- Cite
- Save
Citations (2)
Author Correction: Development of humanized tri-specific nanobodies with potent neutralization for SARS-CoV-2 (Scientific Reports, (2020), 10, 1, (17806), 10.1038/s41598-020-74761-y)

2021 Scientific Reports
Show All
- Source
- Cite
- Save
Citations (0)
Biological activity validation of a computationally designed Rituximab/CD3 T cell engager targeting CD20+ cancers with multiple mechanisms of action

2021
Show All
- Source
- Cite
- Save
Citations (0)
Abstract LB069: Development of cMET/cMET/EGFR Trispecific antibody as therapeutic modality for Non-small Cell Lung Cancer

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Author Correction: Development of humanized tri-specific nanobodies with potent neutralization for SARS-CoV-2

2021 Scientific Reports
Show All
- Source
- Cite
- Save
Citations (0)
A computationally designed Rituximab/CD3 T cell engager targeting CD20+ cancers with multiple mechanisms of action

2021
Show All
- Source
- Cite
- Save
Citations (0)
Development of multi-specific humanized llama antibodies blocking SARS-CoV-2/ACE2 interaction with high affinity and avidity.

2020 Emerging microbes & infections
Show All
- Source
- Cite
- Save
Citations (39)
Development of humanized tri-specific nanobodies with potent neutralization for SARS-CoV-2

2020 Scientific Reports
Show All
- Source
- Cite
- Save
Citations (21)